炎症性肠病患者中回避性限制性食物摄入障碍普遍存在
这项横断面研究纳入161例成人IBD患者,用九条目ARFID筛查量表评估回避性限制性食物摄入障碍(ARFID)风险,发现17%筛查阳性,且阳性者营养不良风险显著更高;活动性症状和炎症与ARFID风险独立相关。
要点
- IBD患者中ARFID风险筛查阳性率为17%,需关注进食行为异常。
- 活动性症状和炎症是ARFID风险的独立相关因素。
- ARFID风险阳性者营养不良风险显著升高,应转诊注册营养师。
核心结论
- IBD患者中回避性进食行为常见,即使在临床缓解期也存在。
- 活动性症状和/或炎症患者应筛查ARFID风险并转诊注册营养师。
研究设计与样本
- 横断面研究,从门诊招募161例成人IBD患者,包括克罗恩病45.3%、溃疡性结肠炎51.6%、IBD未分类3.1%。
- 使用九条目ARFID筛查量表评估ARFID风险,患者生成主观全面评估测量营养风险,逻辑回归分析临床特征与ARFID风险阳性的关联。
主要发现
- 28例(17%)ARFID风险筛查阳性(评分≥24)。
- 92%的参与者在有活动症状时避免至少1种食物,74%在无症状时仍避免至少1种食物。
- 活动性症状与ARFID风险阳性的比值比为5.35(95%CI 1.91-15.01),炎症的比值比为3.31(95%CI 1.06-10.29)。
- ARFID风险阳性者营养不良风险显著更高(60.7% vs 15.8%;P < .01)。
关键数值与推荐
- ARFID风险阳性定义为九条目ARFID筛查量表评分≥24。
- 营养不良风险用患者生成主观全面评估测量。
临床怎么用
- 对IBD患者,尤其是有活动性症状和/或炎症者,应筛查ARFID风险。
- ARFID风险阳性者应转诊注册营养师,以监测和处理进食行为异常及营养不良风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) alter their dietary behaviors to reduce disease-related symptoms, avoid feared food triggers, and control inflammation. This study aimed to estimate the prevalence of avoidant/restrictive food intake disorder (ARFID), evaluate risk factors, and examine the association with risk of malnutrition in patients with IBD. METHODS: This cross-sectional study recruited adult patients with IBD from an ambulatory clinic. ARFID risk was measured using the Nine-Item ARFID Screen. Nutritional risk was measured with the Patient Generated-Subjective Global Assessment. Logistic regression models were used to evaluate the association between clinical characteristics and a positive ARFID risk screen. Patient demographics, disease characteristics, and medical history were abstracted from medical records. RESULTS: Of the 161 participants (Crohn's disease, 45.3%; ulcerative colitis, 51.6%; IBD-unclassified, 3.1%), 28 (17%) had a positive ARFID risk score (≥24). Most participants (92%) reported avoiding 1 or more foods while having active symptoms, and 74% continued to avoid 1 or more foods even in the absence of symptoms. Active symptoms (odds ratio, 5.35; 95% confidence interval, 1.91-15.01) and inflammation (odds ratio, 3.31; 95% confidence interval, 1.06-10.29) were significantly associated with positive ARFID risk. Patients with a positive ARFID risk screen were significantly more likely to be at risk for malnutrition (60.7% vs 15.8%; P < .01). CONCLUSIONS: Avoidant eating behaviors are common in IBD patients, even when in clinical remission. Patients who exhibit active symptoms and/or inflammation should be screened for ARFID risk, with referrals to registered dietitians to help monitor and address disordered eating behaviors and malnutrition risk.
引用
- Yelencich E, Truong E, Widaman AM, et al. Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2021. PMID: 34389486. doi:10.1016/j.cgh.2021.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。